Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients’ Sera

Currently, there are no reliable biomarkers for the diagnosis of pancreatic cancer (PaC). Glycoproteomic approaches that analyze the glycan determinants on specific glycoproteins have proven useful to develop more specific cancer biomarkers than the corresponding protein levels. In PaC, mesothelin (...

Descripción completa

Detalles Bibliográficos
Autores principales: Duran, Adrià, Guerrero, Pedro E., Ortiz, Maria Rosa, Pérez del Campo, Dúnia, Castro, Ernesto, Garcia-Velasco, Adelaida, Fort, Esther, de Llorens, Rafael, Saldova, Radka, Llop, Esther, Peracaula, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405996/
https://www.ncbi.nlm.nih.gov/pubmed/36009489
http://dx.doi.org/10.3390/biomedicines10081942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405996/
https://www.ncbi.nlm.nih.gov/pubmed/36009489
http://dx.doi.org/10.3390/biomedicines10081942

Ejemplares similares